Diversity of ARSACS Mutations in French-Canadians

Abstract: Background: The growing number of spastic ataxia of Charlevoix-Saguenay (SACS) gene mutations reported worldwide has broadened the clinical phenotype of autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). The identification of Quebec ARSACS cases without two known SACS mutation led to the development of a multi-modal genomic strategy to uncover mutations in this large gene and explore phenotype variability. Methods: Search for SACS mutations by combining various methods on 20 cases with a classical French-Canadian ARSACS phenotype without two mutations and a group of 104 sporadic or recessive spastic ataxia cases of unknown cause. Western blot on lymphoblast protein from cases with different genotypes was probed to establish if they still expressed sacsin. Results: A total of 12 mutations, including 7 novels, were uncovered in Quebec ARSACS cases. The screening of 104 spastic ataxia cases of unknown cause for 98 SACS mutations did not uncover carriers of two mutations. Compounds heterozygotes for one missense SACS mutation were found to minimally express sacsin. Conclusions: The large number of SACS mutations present even in Quebec suggests that the size of the gene alone may explain the great genotypic diversity. This study does not support an expanding ARSACS phenotype in the French-Canadian population. Most mutations lead to loss of function, though phenotypic variability in other populations may reflect partial loss of function with preservation of some sacsin expression. Our results also highlight the challenge of SACS mutation screening and the necessity to develop new generation sequencing methods to ensure low cost complete gene sequencing.

[1]  Jean-Pierre Bouchard,et al.  Mutations in the Mitochondrial Methionyl-tRNA Synthetase Cause a Neurodegenerative Phenotype in Flies and a Recessive Ataxia (ARSAL) in Humans , 2012, PLoS biology.

[2]  E. Shoubridge,et al.  Mitochondrial dysfunction and Purkinje cell loss in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) , 2012, Proceedings of the National Academy of Sciences.

[3]  Efraín Siller,et al.  The neurodegenerative-disease-related protein sacsin is a molecular chaperone. , 2011, Journal of molecular biology.

[4]  V. Narayanan,et al.  Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay , 2011, Journal of child neurology.

[5]  E. Schon,et al.  Mitochondria: The Next (Neurode)Generation , 2011, Neuron.

[6]  D. Devos,et al.  Thickening of Peripapillar Retinal Fibers for the Diagnosis of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay , 2011, The Cerebellum.

[7]  B. Brais,et al.  Structural Basis of Defects in the Sacsin HEPN Domain Responsible for Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS)* , 2011, The Journal of Biological Chemistry.

[8]  W. Robberecht,et al.  Mutations in SACS cause atypical and late-onset forms of ARSACS , 2010, Neurology.

[9]  Efraín Siller,et al.  The sacsin repeating region (SRR): a novel Hsp90-related supra-domain associated with neurodegeneration. , 2010, Journal of molecular biology.

[10]  D. Guernsey,et al.  Novel mutations in the sacsin gene in ataxia patients from Maritime Canada , 2010, Journal of the Neurological Sciences.

[11]  F. Cremers,et al.  Design and validation of a conformation sensitive capillary electrophoresis-based mutation scanning system and automated data analysis of the more than 15 kbp-spanning coding sequence of the SACS gene. , 2009, Journal of Molecular Diagnostics.

[12]  R. Carrozzo,et al.  An inherited large-scale rearrangement in SACS associated with spastic ataxia and hearing loss , 2009, neurogenetics.

[13]  K. Boycott,et al.  Homozygous contiguous gene deletion of 13q12 causing LGMD2C and ARSACS in the same patient , 2009, Muscle & nerve.

[14]  T. Webb,et al.  The ataxia protein sacsin is a functional co-chaperone that protects against polyglutamine-expanded ataxin-1 , 2009, Human molecular genetics.

[15]  J. Cruysberg,et al.  ARSACS in the Dutch population: a frequent cause of early-onset cerebellar ataxia , 2008, neurogenetics.

[16]  K. Devriendt,et al.  A novel genomic disorder: a deletion of the SACS gene leading to Spastic Ataxia of Charlevoix–Saguenay , 2008, European Journal of Human Genetics.

[17]  Joseph T. Glessner,et al.  PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. , 2007, Genome research.

[18]  J. Bouchard,et al.  Clinical and genetic study of autosomal recessive cerebellar ataxia type 1 , 2007 .

[19]  I. Thiffault,et al.  A new autosomal recessive spastic ataxia associated with frequent white matter changes maps to 2q33-34. , 2006, Brain : a journal of neurology.

[20]  J. Bouchard,et al.  Hereditary Ataxia, Spastic Paraparesis and Neuropathy in the French-Canadian Population , 2006, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[21]  S. Watanabe,et al.  A novel sacsin mutation in a Japanese woman showing clinical uniformity of autosomal recessive spastic ataxia of Charlevoix-Saguenay , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[22]  D. Labuda,et al.  Mutations in senataxin responsible for Quebec cluster of ataxia with neuropathy , 2005, Annals of neurology.

[23]  E. Lander,et al.  ARSACS, a spastic ataxia common in northeastern Québec, is caused by mutations in a new gene encoding an 11.5-kb ORF , 2000, Nature Genetics.

[24]  T. Hudson,et al.  Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) , 1979, Neuromuscular Disorders.

[25]  J. Sanes,et al.  Mutations in SYNE1 lead to a newly discovered form of autosomal recessive cerebellar ataxia , 2007, Nature Genetics.

[26]  David L. Cardozo,et al.  THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES , 2002 .

[27]  J. Bouchard,et al.  Genetic epidemiology of autosomal recessive spastic ataxia of Charlevoix‐Saguenay in northeastern Quebec , 1993, Genetic epidemiology.